Abstract
Major depression (MD) is a public health problem that is associated with grave consequences in terms of excessive mortality, disability, and secondary morbidity. Indeed, it ranked fourth in 1990 and could rise to second by 2020 in terms of the overall burden of all diseases worldwide. Therefore, it is now clear that current research on the health impact of depression should go beyond estimating its prevalence, symptoms severity, and complications to include studies that seek to establish how it influences the quality of life (QOL) of the affected individuals. In the present chapter we will outline how measures of QOL may reveal differences between patients with depression and control groups, be sensitive to change in status during treatment, have predictive value for outcome measures and provide additional information about timelines for improvement in psychosocial functioning, which may occur at a different rate than changes in other depressive symptoms. More specifically, we will summarize recent investigations that have generally shown that: (1) depressed patients have QOL deficits that are directly attributable to the mood disturbance, (2) the degree of the decrement in QOL is proportional to the severity of depressive symptoms, (3) the negative relation between depression and QOL is as great as (or worse than) that observed in chronic medical disorders such as rheumatoid arthritis and diabetes, and (4) the adequate treatment of depression is usually associated with a significant improvement in the QOL of patients. Finally, we will discuss future perspectives involved in the evaluation of QOL in populations of depressed subjects
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bland, R.C. Epidemiology of affective disorders: a review. Can J Psychiatry 42, 367–77 (1997).
Parikh, S.V. & Lam, R.W. Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden. Can J Psychiatry 46 Suppl 1, 13S–20S (2001).
Doris, A., Ebmeier, K. & Shajahan, P. Depressive illness. Lancet 354, 1369–75 (1999)
Andrews, G., Sanderson, K., Slade, T. & Issakidis, C. Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bull World Health Organ 78, 446–54 (2000)
Hall, R.C. & Wise, M.G. The clinical and financial burden of mood disorders. Cost and outcome. Psychosomatics 36, S11–8 (1995).
Sartorius, N. The economic and social burden of depression. J Clin Psychiatry 62 Suppl 15, 8–11 (2001).
Murray, C.J. & Lopez, A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436–42 (1997)
Ballenger, J.C. et al. Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 60 Suppl 7, 54–61 (1999).
Greden, J.F. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 62 Suppl 22, 5–9 (2001).
Angst, J., Angst, F. & Stassen, H.H. Suicide risk in patients with major depressive disorder. J Clin Psychiatry 60 Suppl 2, 57–62; discussion 75–6, 113–6 (1999).
Demyttenaere, K., De Fruyt, J. & Huygens, R. Measuring quality of life in depression. Current Opinion in Psychiatry 15, 89–92 (2002)
Berlim, M.T., Mattevi, B.S. & Fleck, M.P. Depression and quality of life among depressed Brazilian outpatients. Psychiatr Serv 54, 254 (2003).
Papakostas, G.I. et al. Quality of life assessments in major depressive disorder: a review of the literature. Gen Hosp Psychiatry 26, 13–7 (2004).
Kennedy, S.H., Eisfeld, B.S. & Cooke, R.G. Quality of life: an important dimension in assessing the treatment of depression? J Psychiatry Neurosci 26 Suppl, S23–8 (2001).
Berlim, M.T. & Fleck, M.P. "Quality of life": a brand new concept for research and practice in psychiatry. Rev Bras Psiquiatr 25, 249–52 (2003).
Orley, J., Saxena, S. & Herrman, H. Quality of life and mental illness. Reflections from the perspective of the WHOQOL. Br J Psychiatry 172, 291–3 (1998).
Fleck, M.P.A. Avaliação de qualidade de vida. in Depressões em Medicina Interna e em Outras Condições Mèdicas (eds. Fràguas, R. & Figueirò, J.A.B.) 235–257 (Editora Atheneu, São Paulo, 2001).
Beck, A.T., Rush, A.J., Shaw, B.F. & Emery, G. Cognitive therapy of depression: A treatment manual, (Guilford Press, New York, 1979).
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med 28, 551–8 (1998)
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23, 56–62 (1960).
Rocha, N., Power, M., Fleck, M.P. & Bushnell, D. What are we measuring using WHOQOL-Bref in depressed patients? The LIDO experience. Qual of Life Res 14 2016 (2003).
Beck, A.T., Ward, C.H., Mendelson, M., Mock, J. & Erbaugh, J. An inventory for measuring depression. Arch Gen Psychiatry 4, 561–71 (1961)
Berlim, M.T. et al. Psychache and suicidality in adult mood disordered outpatients in Brazil. Suicide Life Threat Behav 33, 242–8 (2003)
Fleck, M.P. et al. [Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100)]. Rev Saude Publica 33, 198–205 (1999)
Aigner, M. et al. What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder. Soc Psychiatry Psychiatr Epidemiol 41, 81–6 (2006)
Katschnig, H. & Angermeyer, M. Quality of Life in Depression. in Quality of Life in Mental Disorders (eds. Katschnig, H., Freeman, H. & Sartorius, N.) 137–147 (John Wiley & Sons, New York, 1997).
Fleck, M.P. et al. [Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref]. Rev Saude Publica 34, 178–83 (2000).
Berlim, M.T., Pavanello, D.P., Caldieraro, M.A. & Fleck, M.P. Reliability and validity of the WHOQOL BREF in a sample of Brazilian outpatients with major depression. Qual Life Res 14, 561–4 (2005)
McCall, W.V., Reboussin, B.A. & Rapp, S.R. Social support increases in the year after inpatient treatment of depression. J Psychiatr Res 35, 105–10 (2001).
McKenna, S.P. et al. International development of the Quality of Life in Depression Scale (QLDS). J Affect Disord 63, 189–99 (2001)
Fleck, M.P. et al. Longitudinal Investigation of Depression Outcomes Group: Major depression and its correlates in primary care settings in six countries. 9-month follow-up study. Br J Psychiatry 186:(2005).
Berlim, M.T., Mattevi, B.S., Pavanello, D.P., Caldieraro, M.A. & Fleck, M.P. Suicidal ideation and quality of life among adult Brazilian outpatients with depressive disorders. J Nerv Ment Dis 191, 193–7 (2003).
Berlim, M.T. et al. Quality of life in unipolar and bipolar depression: are there significant differences? J Nerv Ment Dis 192, 792–5 (2004).
Hunt, S.M. & McKenna, S.P. The QLDS: a scale for the measurement of quality of life in depression. Health Policy 22, 307–19 (1992).
Endicott, J., Nee, J., Harrison, W. & Blumenthal, R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 29, 321–6 (1993)
Guy, W. ECDEU Assessment Manual for Psychopharmacology, (U.S. Department of Health, Education, and Welfare, Washington, D.C.,, 1976).
Stoker, M.J., Dunbar, G.C. & Beaumont, G. The SmithKline Beecham ‘quality of life’ scale: a validation and reliability study in patients with affective disorder. Qual Life Res 1, 385–95 (1992)
Bergner, M., Bobbitt, R.A., Carter, W.B. & Gilson, B.S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 19, 787–805 (1981)
Goldberg, D.P. & Hillier, V.F. A scaled version of the General Health Questionnaire. Psychol Med 9, 139–45 (1979)
Goldney, R.D., Fisher, L.J., Wilson, D.H. & Cheok, F. Major depression and its associated morbidity and quality of life in a random, representative Australian community sample. Aust N Z J Psychiatry 34, 1022–9 (2000).
Rapaport, M.H., Clary, C., Fayyad, R. & Endicott, J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162, 1171–8 (2005)
Wells, K.B. et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. Jama 262, 914–9 (1989).
Hays, R.D., Wells, K.B., Sherbourne, C.D., Rogers, W. & Spritzer, K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 52, 11–9 (1995).
Miller, I.W. et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 59, 608–19 (1998)
Barge-Schaapveld, D.Q. & Nicolson, N.A. Effects of antidepressant treatment on the quality of daily life: an experience sampling study. J Clin Psychiatry 63, 477–85 (2002)
Skevington, S.M. Advancing cross-cultural research on quality of life: observations drawn from the WHOQOL development. World Health Organisation Quality of Life Assessment. Qual Life Res 11, 135–44 (2002).
Skevington, S.M. & Wright, A. Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br J Psychiatry 178, 261–7 (2001)
De Lisio, G. et al. Impairment of work and leisure in depressed outpatients. A preliminary communication. J Affect Disord 10, 79–84 (1986).
Kocsis, J.H. et al. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo. Arch Gen Psychiatry 59, 723–8 (2002)
Souetre, E., Martin, P., Lozet, H. & Monteban, H. Quality of life in depressed patients: comparison of fluoxetine and major tricyclic antidepressants. Int Clin Psychopharmacol 11, 45–52 (1996)
Pyne, J.M. et al. Health-related quality-of-life measure enhances acute treatment response prediction in depressed inpatients. J Clin Psychiatry 62, 261–8 (2001).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 springer
About this chapter
Cite this chapter
Berlim, M.T., Fleck, M.P. (2007). Quality of Life and Major Depression. In: Ritsner, M.S., Awad, A.G. (eds) Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5779-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-4020-5779-3_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5777-9
Online ISBN: 978-1-4020-5779-3
eBook Packages: MedicineMedicine (R0)